Le Lézard
Classified in: Health
Subjects: PDT, BFA, VET, DEI

Video: How Veterans' Needs Are Changing Healthcare Today

Watch the 4-minute video produced by VITAS® Healthcare: https://bcove.video/3RumwQa

MIAMI, Nov. 8, 2022 /PRNewswire/ -- Each day, US veterans from the Greatest Generation, those who battled in WWII, become a smaller subset of the living veteran population. Service members who fought in the Korean War and Vietnam War are now the largest veteran group requiring care as they near the end of life?and their needs vary significantly from the generation before. In a new video produced by VITAS® Healthcare, veteran clinicians and healthcare professionals describe the changing needs and how care must adapt to meet these needs.

There are 5.6M Vietnam War veterans living today, many are nearing the end of life and with highly individualized needs.

Watch the video: https://bcove.video/3RumwQa

The Department of Veterans Affairs currently projects that there are 5.6 million Vietnam War veterans living today. Many of these veterans are nearing the end of life and with highly individualized needs.

The circumstances associated with this unique period of service have impacted the aging veteran population with health issues including toxic exposure (from burn pits and Agent Orange) and psychological trauma. Hospice care, provided by VITAS, takes measures to manage each of these complex health concerns and address the unique needs of Vietnam veterans.

"There's also moral injury," notes Faith Protsman, MD, US Army veteran and VITAS regional medical director. "Most of our veterans grew up with values that are so different from what they had to do in the Military. We see it at the end-of-life when their defenses are not as strong."

Moral injury often stems from factors such as unwanted service due to the draft, serving in an unfavorable war, and a lack of appreciation from their fellow countrymen when returning from their service to the nation.

Toxic exposure has been linked to leukemia, Hodgkin's disease, non-Hodgkin's lymphoma, myeloma and many other cancers along with Parkinson's, type II diabetes and other non-cancer related diseases.

With expertise in VA benefits and clinical teams focused on creating individualized care plans and interventions, VITAS hospice teams manage symptoms associated with their advanced diseases?which may or may not be a result of their service?while helping veterans receive the benefits to which they are entitled.

VITAS holds pinning ceremonies, gives veterans certificates of recognition and provides bedside salutes to give those who are facing moral injury much-needed solace, acknowledging all that they have sacrificed to preserve the freedoms that Americans hold so dear. It is often these gestures that help Vietnam veterans obtain the closure needed to pass on more peacefully.

The age range for Vietnam War veterans is 62 to 104 years old, making them currently the most prevalent veteran demographic nearing the end of life. As the population shifts, hospice care providers must do all they can to meet the needs of Baby Boomer veterans.

As the nation's leading provider of end-of-life care, VITAS is committed to serving those who have served our country when they need it most. Learn more at VITAS.com/Veterans.

About VITAS® Healthcare

Established in 1978, VITAS Healthcare is a pioneer and leader in the American hospice movement. Headquartered in Miami, Florida, VITAS (pronounced VEE-tahs) operates 50 hospice programs in 14 states (California, Connecticut, Delaware, Florida, Georgia, Illinois, Kansas, Missouri, New Jersey, Ohio, Pennsylvania, Texas, Virginia and Wisconsin) and the District of Columbia. VITAS employs 9,693 professionals who care for patients with advanced illness, primarily in the patients' homes, and also in the company's 25 inpatient hospice units as well as in hospitals, nursing homes and assisted living communities/residential care facilities for the elderly. At the conclusion of the third quarter of 2022, VITAS reported an average daily census of 17,325. Visit www.vitas.com.

Media inquiries contact: [email protected], 877-848-2701


These press releases may also interest you

at 01:05
SeqOne today announced the results of a long-standing research collaboration with Pr. Laurent Mesnard, Co-Director of the French National center for Thrombotic MicroAngiopathies (CNR-MAT), aimed at improving the diagnosis and management of patients...

at 01:00
2022 total sales up by 8.5% at CER1 (14.4% as reported) with growth platforms'2 sales increasing by 20.9%1 and Somatuline® (lanreotide) sales declining by 5.6%12022 core operating margin of 36.9%, broadly in line with 2021; IFRS operating margin of...

at 01:00
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has expanded its collaboration with Janssen Biotech Inc. (Janssen) to...

at 00:00
Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced its commitment to achieve net zero greenhouse gas (GHG) emissions by 2050....

8 fév 2023
Tivic Health® Systems, Inc. ("Tivic") , a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced the pricing of an underwritten public offering of an aggregate of 20,000,000 shares of...

8 fév 2023
The global liver cancer drugs market size is estimated to increase by USD 5.29 billion from 2021 to 2026. The market's growth momentum will accelerate at a CAGR of 14.67%. The report provides a comprehensive analysis of growth opportunities at...

News published on 8 november 2022 at 07:42 and distributed by: